KAYLA RUSSELL: Open Payments
NPI 1437989811 · OZARK, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$180 in 10 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $180
Food & beverage: $180
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $54 |
| Novo Nordisk Inc | 2 | $38 |
| Amgen Inc. | 1 | $23 |
| PFIZER INC. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 1 | $14 |
| ACADIA Pharmaceuticals Inc | 1 | $14 |
Products named: Ozempic, REPATHA, ZEPBOUND, MOUNJARO, NURTEC ODT, FARXIGA, Rybelsus, VOQUEZNA.
Industry payments across AL — which companies pay providers there.
